巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    虛擬市場

    MacroGenics

    MGNX
    3.995
    ▲0.110
    ▲2.70%
    概況消息
    最少15分鐘延遲，股票資訊由第三方資訊供應商提供
    ・MacroGenics - 延遲價格・最後更新於 20/05 12:15
    最高位
    4.140
    最低位
    3.800
    開市價
    --
    前收市價
    3.890
    成交量(千)
    31.24
    成交額(百萬)
    1.03
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    245.03
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    32.810 - 3.760
    所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    MacroGenics
    證券代碼
    MGNX.US
    所屬板塊
    Biotechnology
    公司業務
    Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. The company's strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The company's intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them.
    發行量
    61258001
    公司總部
    9704 Medical Center Drive
    公司網址
    https://www.macrogenics.com
    公司電郵
    info@macrogenics.com
    公司電話
    +1 301 251-5172

    最新發佈

    暫無內容

    關於

    MacroGenics(MGNX.US)所屬的行業板塊為Biotechnology。
    Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. The company's strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The company's intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them.
    詳細公司背景可參考: https://www.macrogenics.com。